Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, China.
School of Biomedical Engineering, Hubei University of Medicine, Shiyan 442000, China.
Carbohydr Polym. 2022 Jun 15;286:119274. doi: 10.1016/j.carbpol.2022.119274. Epub 2022 Feb 23.
As a minimally invasive method, endovascular embolization has been an effective strategy for controlling bleeding and tumor treatment. Herein, carboxymethyl chitin embolic microspheres were prepared with the aqueous two-phase carboxymethyl chitin/polyethylene glycol system without using any crosslinking agents and thrombin-functionalized embolic microsphere named as Thr@CMCHm-30 was made after covalent introduction of thrombin. The size of the microspheres can be adjusted from 5 to 500 μm. The data of in vitro and in vivo tests indicated that these microspheres possessed good degradability and biocompatibility. Meanwhile, Thr@CMCHm-30 can significantly promote blood clotting and enhance the strength of the blood clots. More importantly, Thr@CMCHm-30 displayed better embolization effect than that of the commercial available Gelfoam Alicon® and polyvinyl alcohol-based embolic microspheres CalliSpheres® in rat femoral vein and rabbit ear artery embolization models. Therefore the size-tunable and biodegradable thrombin-functionalized carboxymethyl chitin microspheres Thr@CMCHm-30 possess great potential for effective hemostasis and endovascular embolization.
作为一种微创方法,血管内栓塞已成为控制出血和肿瘤治疗的有效策略。在此,我们使用水相两相法制备了羧甲基壳聚糖/聚乙二醇体系的羧甲基壳聚糖栓塞微球,无需使用任何交联剂,然后通过共价引入凝血酶,制备了凝血酶功能化栓塞微球 Thr@CMCHm-30。微球的粒径可从 5 至 500 μm 进行调节。体外和体内实验数据表明,这些微球具有良好的可降解性和生物相容性。同时,Thr@CMCHm-30 可显著促进血液凝固,增强血栓强度。更重要的是,与商业上可用的 Gelfoam Alicon®和聚乙烯醇基栓塞微球 CalliSpheres®相比,Thr@CMCHm-30 在大鼠股静脉和兔耳动脉栓塞模型中显示出更好的栓塞效果。因此,具有可调粒径和可生物降解性的凝血酶功能化羧甲基壳聚糖微球 Thr@CMCHm-30 具有有效止血和血管内栓塞的巨大潜力。